CG Oncology, Inc. Common stock
CGON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$88,039 | -$48,607 | -$35,443 | -$12,839 |
| Dep. & Amort. | $32 | $17 | $15 | $10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,402 | $1,528 | $676 | $1,112 |
| Change in WC | $2,906 | $3,439 | $4,439 | -$1,967 |
| Other Non-Cash | -$5,014 | -$2,056 | $509 | $30 |
| Operating Cash Flow | -$78,713 | -$45,679 | -$29,804 | -$13,654 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$234 | $0 | -$14 | -$97 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,045,942 | -$517,611 | -$55,338 | $0 |
| Inv. Sales/Matur. | $745,412 | $396,416 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$300,764 | -$121,195 | -$55,352 | -$97 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$365 | -$16,291 | $0 | $15,201 |
| Stock Issued | $629,469 | $0 | $166 | $245 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$825 | $103,288 | $119,526 | $0 |
| Financing Cash Flow | $628,279 | $86,997 | $119,692 | $15,446 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $248,802 | -$79,877 | $34,536 | $1,695 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,266 | $88,143 | $53,607 | $51,912 |
| End Cash | $257,068 | $8,266 | $88,143 | $53,607 |
| Free Cash Flow | -$78,947 | -$45,679 | -$29,818 | -$13,751 |